Congenital Heart Disease (CHD) Global Market Report 2024

Description

Congenital heart disease (CHD) encompasses a spectrum of birth defects affecting the structure and function of the heart present at birth. These defects may involve abnormalities in the heart walls, valves, arteries, and veins near the heart. Treatment for CHD varies depending on the type and severity of the defect and may include medications, catheter-based interventions, open-heart surgery, or heart transplantation.

The primary types of congenital heart disease (CHD) include heart valve defects, heart wall defects, blood vessel defects, and others. Heart valve defects entail abnormalities or malfunctions in the heart valves, which regulate blood flow within the heart. Diagnosis methods may include electrocardiograms, chest X-rays, echocardiograms, transesophageal echocardiograms, pulse oximetry, exercise stress tests, cardiac computed tomography (CT) scans, magnetic resonance imaging (MRI), cardiac catheterization, among others. Treatment options range from interventional cardiology procedures to cardiac surgery, medication management, telemedicine, and lifestyle modifications. CHD affects individuals across all age groups, including infants, children, adolescents, and adults, who receive treatment in hospitals, clinics, diagnostic centers, ambulatory surgical centers, and research and academic institutions.

The congenital heart disease market research report is one of a series of new reports from The Business Research Company that provides congenital heart disease market statistics, including congenital heart disease industry global market size, regional shares, competitors with a congenital heart disease market share, detailed congenital heart disease market segments, market trends and opportunities, and any further data you may need to thrive in the congenital heart disease industry. This congenital heart disease market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The congenital heart disease (CHD) market size has grown strongly in recent years. It will grow from $4.03 billion in 2023 to $4.42 billion in 2024 at a compound annual growth rate (CAGR) of 9.7%. The growth observed during the historic period can be attributed to several factors, including the increased prevalence of risk factors such as obesity and smoking, advancements in diagnostic technologies leading to improved detection rates, a growing geriatric population, heightened awareness campaigns raising public consciousness about congenital heart disease (CHD), improved reimbursement policies facilitating access to healthcare services, and increased investment in research and development aimed at better understanding and treating CHD.

The congenital heart disease (CHD) market size is expected to see strong growth in the next few years. It will grow to $6.43 billion in 2028 at a compound annual growth rate (CAGR) of 9.8%. The anticipated growth in the forecast period can be attributed to several factors, including the expansion of access to healthcare services in developing regions, ongoing innovations in cardiac imaging technologies, increased awareness campaigns advocating for early detection and treatment, rising global healthcare expenditure, and the advancement of personalized medicine. Furthermore, major trends expected in the forecast period encompass the adoption of minimally invasive surgical techniques, the growing utilization of telemedicine for remote patient monitoring and consultations, an increasing demand for personalized treatment approaches, the development of innovative implantable devices with improved functionality and longevity, as well as the integration of artificial intelligence and machine learning into diagnostic and therapeutic processes.

The surge in maternal diabetes cases, specifically gestational diabetes mellitus (GDM), is anticipated to drive the growth of the congenital heart disease (CHD) market. Maternal diabetes, arising during pregnancy in women without pre-existing diabetes, is attributed to lifestyle changes such as sedentary behavior, unhealthy dietary habits, and increasing obesity rates among women of childbearing age. Maternal diabetes poses a risk of congenital heart disease (CHD) in infants due to elevated blood sugar levels impacting fetal heart development. The heightened glucose levels in the mother's bloodstream can disrupt normal fetal heart development, escalating the risk of CHD. For example, in January 2023, the Centers for Disease Control and Prevention reported an increase in the percentage of pregnant mothers diagnosed with gestational diabetes to 8.3% in 2021 from 6.0% in the preceding five years. Consequently, the rise in maternal diabetes cases is propelling the expansion of the congenital heart disease (CHD) market.

Key players in the congenital heart disease market are innovating non-surgical heart valves to enhance patient outcomes and quality of life. Non-surgical heart valves, also known as transcatheters, are medical devices treating heart valve diseases without conventional open-heart surgery. For instance, in February 2023, Medtronic, a US-based medical technology company, reintroduced its Harmony Transcatheter Pulmonary Valve (TPV) System. This system, a minimally invasive alternative to open-heart surgery, addresses patients with congenital heart disease, particularly those with native or surgically repaired right ventricular outflow tract (RVOT) anomalies. It stands as the first FDA-approved valve designed for the right side, offering a non-surgical solution for severe pulmonary valve regurgitation patients. The Harmony TPV System received U.S. FDA approval in 2021 and was reintroduced following a voluntary recall, underscoring Medtronic's dedication to advancing solutions for congenital heart disease patients.

In December 2021, Venus MedTech HangZhou Inc., a China-based medical device company, acquired Cardiovalve Ltd. for $300 million. This strategic acquisition bolsters Venus MedTech's presence in mitral and tricuspid valve replacement, positioning it as a comprehensive platform company and unlocking opportunities for innovation and international expansion. Cardiovalve Ltd., based in Israel, specializes in transcatheter mitral and tricuspid valve treatments, manufacturing heart valves for cardiac surgery.

Major companies operating in the congenital heart disease (CHD) market are Pfizer Inc., AstraZeneca Plc, Abbott Laboratories, Novartis AG, Medtronic, Siemens Healthineers, Philips Healthcare, Roche Diagnostics International Ltd., Boston Scientific Corp., Laboratory Corporation of America Holdings (LabCorp), Terumo Corporation, Mindray Medical International Limited, Canon Medical Systems Corporation, Masimo Corporation, Neusoft Corp., Carestream Health, Midmark Corporation, Contec Medical Systems, Randox Laboratories Ltd., Schiller AG, BPL Medical Technologies, Compumedics Limited, Biocare Medical, Bionet America Inc., Nasan Medical Electronics Pvt Ltd

North America was the largest region in the congenital heart disease (CHD) market in 2023. The regions covered in the congenital heart disease (CHD) market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the congenital heart disease (CHD) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The congenital heart disease (CHD) market consists of revenues earned by entities by providing services such as medical consultations, diagnostic tests, and support services. The market value includes the value of related goods sold by the service provider or included within the service offering. The congenital heart disease (CHD) market also includes sales of cardiac implants such as pacemakers, implantable cardioverter-defibrillators (ICDs), and ventricular assist devices (VADs). Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Congenital Heart Disease (CHD) Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on congenital heart disease (CHD) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for congenital heart disease (CHD)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The congenital heart disease (CHD) market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of COVID-19 on supply chains and consumption patterns.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Heart Valve Defects; Heart Wall Defects; Blood Vessel Defects; Other Types
2) By Diagnosis: Electrocardiogram; Chest X-ray; Echocardiogram; Transesophageal Echocardiogram; Pulse Oximetry; Exercise Stress Test; Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI); Cardiac Catheterization; Other Diagnosis
3) By Treatment: Interventional Cardiology; Cardiac Surgery; Telemedicine; Medication Management; Lifestyle Modifications
4) By Age Group: Infants; Children; Adolescents; Adults
5) By Application: Hospitals And Clinics; Diagnostic Centers; Ambulatory Surgical Centers; Research And Academic Institutions
Companies Mentioned: Pfizer Inc.; AstraZeneca Plc; Abbott Laboratories; Novartis AG; Medtronic
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r18111

1. Executive Summary

2. Congenital Heart Disease (CHD) Market Characteristics

3. Congenital Heart Disease (CHD) Market Trends And Strategies

4. Congenital Heart Disease (CHD) Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Congenital Heart Disease (CHD) Market Size and Growth

5.1. Global Congenital Heart Disease (CHD) Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Congenital Heart Disease (CHD) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Congenital Heart Disease (CHD) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Congenital Heart Disease (CHD) Market Segmentation

6.1. Global Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Heart Valve Defects
Heart Wall Defects
Blood Vessel Defects
Other Types
6.2. Global Congenital Heart Disease (CHD) Market, Segmentation By Diagnosis, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Electrocardiogram
Chest X-ray
Echocardiogram
Transesophageal Echocardiogram
Pulse Oximetry
Exercise Stress Test
Cardiac Computed Tomography (CT) Scan Or Magnetic Resonance Imaging (MRI)
Cardiac Catheterization
Other Diagnosis
6.3. Global Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Interventional Cardiology
Cardiac Surgery
Telemedicine
Medication Management
Lifestyle Modifications
6.4. Global Congenital Heart Disease (CHD) Market, Segmentation By Age Group, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Infants
Children
Adolescents
Adults
6.5. Global Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals And Clinics
Diagnostic Centers
Ambulatory Surgical Centers
Research And Academic Institutions

7. Congenital Heart Disease (CHD) Market Regional And Country Analysis

7.1. Global Congenital Heart Disease (CHD) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Congenital Heart Disease (CHD) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Congenital Heart Disease (CHD) Market

8.1. Asia-Pacific Congenital Heart Disease (CHD) Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Congenital Heart Disease (CHD) Market

9.1. China Congenital Heart Disease (CHD) Market Overview
9.2. China Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Congenital Heart Disease (CHD) Market

10.1. India Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Congenital Heart Disease (CHD) Market

11.1. Japan Congenital Heart Disease (CHD) Market Overview
11.2. Japan Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Congenital Heart Disease (CHD) Market

12.1. Australia Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Congenital Heart Disease (CHD) Market

13.1. Indonesia Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Congenital Heart Disease (CHD) Market

14.1. South Korea Congenital Heart Disease (CHD) Market Overview
14.2. South Korea Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Congenital Heart Disease (CHD) Market

15.1. Western Europe Congenital Heart Disease (CHD) Market Overview
15.2. Western Europe Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Congenital Heart Disease (CHD) Market

16.1. UK Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Congenital Heart Disease (CHD) Market

17.1. Germany Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Congenital Heart Disease (CHD) Market

18.1. France Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Congenital Heart Disease (CHD) Market

19.1. Italy Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Congenital Heart Disease (CHD) Market

20.1. Spain Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Congenital Heart Disease (CHD) Market

21.1. Eastern Europe Congenital Heart Disease (CHD) Market Overview
21.2. Eastern Europe Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Congenital Heart Disease (CHD) Market

22.1. Russia Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Congenital Heart Disease (CHD) Market

23.1. North America Congenital Heart Disease (CHD) Market Overview
23.2. North America Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Congenital Heart Disease (CHD) Market

24.1. USA Congenital Heart Disease (CHD) Market Overview
24.2. USA Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Congenital Heart Disease (CHD) Market

25.1. Canada Congenital Heart Disease (CHD) Market Overview
25.2. Canada Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Congenital Heart Disease (CHD) Market

26.1. South America Congenital Heart Disease (CHD) Market Overview
26.2. South America Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Congenital Heart Disease (CHD) Market

27.1. Brazil Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Congenital Heart Disease (CHD) Market

28.1. Middle East Congenital Heart Disease (CHD) Market Overview
28.2. Middle East Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Congenital Heart Disease (CHD) Market

29.1. Africa Congenital Heart Disease (CHD) Market Overview
29.2. Africa Congenital Heart Disease (CHD) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Congenital Heart Disease (CHD) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Congenital Heart Disease (CHD) Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Congenital Heart Disease (CHD) Market Competitive Landscape And Company Profiles

30.1. Congenital Heart Disease (CHD) Market Competitive Landscape
30.2. Congenital Heart Disease (CHD) Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. AstraZeneca Plc
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Abbott Laboratories
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Novartis AG
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. Medtronic
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Congenital Heart Disease (CHD) Market Other Major And Innovative Companies

31.1. Siemens Healthineers
31.2. Philips Healthcare
31.3. Roche Diagnostics International Ltd.
31.4. Boston Scientific Corp.
31.5. Laboratory Corporation of America Holdings (LabCorp)
31.6. Terumo Corporation
31.7. Mindray Medical International Limited
31.8. Canon Medical Systems Corporation
31.9. Masimo Corporation
31.10. Neusoft Corp.
31.11. Carestream Health
31.12. Midmark Corporation
31.13. Contec Medical Systems
31.14. Randox Laboratories Ltd.
31.15. Schiller AG

32. Global Congenital Heart Disease (CHD) Market Competitive Benchmarking

33. Global Congenital Heart Disease (CHD) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Congenital Heart Disease (CHD) Market

35. Congenital Heart Disease (CHD) Market Future Outlook and Potential Analysis

35.1 Congenital Heart Disease (CHD) Market In 2028 - Countries Offering Most New Opportunities
35.2 Congenital Heart Disease (CHD) Market In 2028 - Segments Offering Most New Opportunities
35.3 Congenital Heart Disease (CHD) Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer